VISTA is an acidic pH-selective ligand for PSGL-1-Reference-Cited by-同舟云学术

VISTA is an acidic pH-selective ligand for PSGL-1

Published:2019-10-23 Issue:7779 Volume:574 Page:565-570
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Johnston Robert J.,Su Linhui Julie,Pinckney Jason,Critton David,Boyer Eric,Krishnakumar Arathi,Corbett Martin,Rankin Andrew L.,Dibella Rose,Campbell Lynne,Martin Gaelle H.,Lemar Hadia,Cayton Thomas,Huang Richard Y.-C.,Deng Xiaodi,Nayeem Akbar,Chen Haibin,Ergel Burce,Rizzo Joseph M.,Yamniuk Aaron P.,Dutta Sanjib,Ngo Justine,Shorts Andrea Olga,Ramakrishnan Radha,Kozhich Alexander,Holloway Jim,Fang Hua,Wang Ying-Kai,Yang Zheng,Thiam Kader,Rakestraw Ginger,Rajpal Arvind,Sheppard Paul,Quigley Michael,Bahjat Keith S.,Korman Alan J.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-019-1674-5.pdf

Reference47 articles.

1. Thommen, D. S. & Schumacher, T. N. T cell dysfunction in cancer. Cancer Cell 33, 547–562 (2018).

2. McLane, L. M., Abdel-Hakeem, M. S. & Wherry, E. J. CD8 T cell exhaustion during chronic viral infection and cancer. Annu. Rev. Immunol. 37, 457–495 (2019).

3. Ribas, A. & Wolchok, J. D. Cancer immunotherapy using checkpoint blockade. Science 359, 1350–1355 (2018).

4. Wang, L. et al. VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses. J. Exp. Med. 208, 577–592 (2011).

5. Flies, D. B., Wang, S., Xu, H. & Chen, L. Cutting edge: A monoclonal antibody specific for the programmed death-1 homolog prevents graft-versus-host disease in mouse models. J. Immunol. 187, 1537–1541 (2011).

Cited by 249 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A functional role for glycosylated B7-H5/VISTA immune checkpoint protein in metastatic clear cell renal cell carcinoma;iScience;2024-09

2. Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective;eBioMedicine;2024-09

3. Novel insights into the regulation of exosomal PD-L1 in cancer: From generation to clinical application;European Journal of Pharmacology;2024-09

4. Advances in immunotherapy for breast cancer and feline mammary carcinoma: From molecular basis to novel therapeutic targets;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

5. Eliminating a barrier: Aiming at VISTA, reversing MDSC-mediated T cell suppression in the tumor microenvironment;Heliyon;2024-09